Champions Oncology, Inc.

CSBR

Champions Oncology, Inc. (CSBR) is a provider of personalized cancer immunotherapy solutions. The company develops and offers patient-derived tumor models to help guide treatment decisions and accelerate drug development. Through its platform, Champions Oncology enables more effective and targeted cancer therapies by allowing researchers and clinicians to evaluate the efficacy of various treatments on individual patient samples.

$6.13 +0.29 (4.97%)
🚫 Champions Oncology, Inc. does not pay dividends

Company News

Champions Oncology (CSBR) Earnings Transcript
The Motley Fool • Motley Fool Transcribing • March 13, 2026

Champions Oncology reported Q3 FY2026 results with record core study revenue of $16.6 million (up 32% YoY), but overall revenue declined 3% due to absence of data revenue. The company achieved its third consecutive quarter of positive adjusted EBITDA at $575,000. Gross margins fell to 47% from 61% due to $2M in outsourced radiolabeling costs. Man...

Insiders Buying Solid Biosciences And 2 Other Stocks
Benzinga • Avi Kapoor • January 16, 2024

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for mak...

Insiders Buying Tilly's And 2 Other Stocks
Benzinga • Avi Kapoor • January 10, 2024

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for ma...

Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday
Benzinga • Avi Kapoor • December 12, 2023

With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Johnson Controls International plc (NYSE: JCI) to report quarterly earnings at $1.09 per share on revenue of $7.09 billion before the opening bell. Johnson Controls shares rose 1.6% to $57.50...

Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day
Benzinga • Avi Kapoor • December 12, 2023

The CNN Money Fear and Greed index showed further improvement in overall market sentiment, while the index remained in the "Greed" zone on Monday. U.S. stocks closed higher on Monday, with the Dow Jones index recording its highest close since Jan. 2022. Data on consumer price index for November will be released on Tuesday, while the producer pric...

Related Companies